Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,126 | 221 | 93.6% |
| Travel and Lodging | $268.85 | 1 | 6.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11.77 | 1 | 0.3% |
| Education | $3.71 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neuronetics, Inc. | $960.30 | 12 | $0 (2019) |
| Shire North American Group Inc | $548.76 | 51 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $440.18 | 28 | $0 (2024) |
| Tris Pharma Inc | $342.26 | 17 | $0 (2021) |
| ABBVIE INC. | $225.33 | 13 | $0 (2022) |
| Vanda Pharmaceuticals Inc. | $219.02 | 10 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $213.96 | 15 | $0 (2020) |
| Lundbeck LLC | $177.03 | 9 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $155.15 | 3 | $0 (2023) |
| Indivior Inc. | $153.05 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35.64 | 2 | Otsuka America Pharmaceutical, Inc. ($35.64) |
| 2023 | $177.50 | 3 | Janssen Pharmaceuticals, Inc ($130.01) |
| 2022 | $15.01 | 1 | ABBVIE INC. ($15.01) |
| 2021 | $298.13 | 16 | AbbVie Inc. ($210.32) |
| 2020 | $369.63 | 20 | Tris Pharma Inc ($130.57) |
| 2019 | $1,610 | 59 | Neuronetics, Inc. ($720.86) |
| 2018 | $979.62 | 57 | Shire North American Group Inc ($222.65) |
| 2017 | $924.66 | 66 | Shire North American Group Inc ($279.18) |
All Payment Transactions
224 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: PSYCHIATRY | ||||||
| 05/15/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: PSYCHIATRY | ||||||
| 08/08/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: NEUROSCIENCE | ||||||
| 03/31/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $130.01 | General |
| Category: Neuroscience | ||||||
| 05/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.23 | General |
| Category: PSYCHOLOGY | ||||||
| 08/17/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2021 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: ADHD | ||||||
| 06/24/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2021 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: ADHD | ||||||
| 05/24/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: NEUROSCIENCE | ||||||
| 05/05/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: NEUROSCIENCE | ||||||
| 04/21/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: NEUROSCIENCE | ||||||
| 03/31/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: NEUROSCIENCE | ||||||
| 03/17/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: NEUROSCIENCE | ||||||
| 02/12/2021 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: ADHD | ||||||
| 01/20/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2020 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: ADHD | ||||||
| 08/28/2020 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 42 | 152 | $26,199 | $9,405 |
| 2022 | 1 | 11 | 21 | $3,150 | $1,517 |
| 2021 | 3 | 126 | 307 | $43,815 | $22,036 |
| 2020 | 3 | 189 | 516 | $67,390 | $31,708 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 129 | $20,511 | $7,607 | 37.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $3,432 | $1,075 | 31.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 12 | 12 | $2,256 | $722.40 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 21 | $3,150 | $1,517 | 48.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 73 | 215 | $35,435 | $17,235 | 48.6% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 26 | 51 | $4,335 | $2,439 | 56.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 41 | $4,045 | $2,362 | 58.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 79 | 271 | $44,255 | $19,141 | 43.3% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 55 | 129 | $10,925 | $6,305 | 57.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 55 | 116 | $12,210 | $6,262 | 51.3% |
About Dr. Praveen Pathak, M.D
Dr. Praveen Pathak, M.D is a Psychiatry healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386613867.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Praveen Pathak, M.D has received a total of $4,410 in payments from pharmaceutical and medical device companies, with $35.64 received in 2024. These payments were reported across 224 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,126).
As a Medicare-enrolled provider, Pathak has provided services to 368 Medicare beneficiaries, totaling 996 services with total Medicare billing of $64,665. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Springfield, MO
- Active Since 03/16/2006
- Last Updated 02/21/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1386613867
Products in Payments
- NEUROSTAR TMS THERAPY (Device) $837.84
- REXULTI (Drug) $382.07
- Dyanavel XR (Drug) $325.96
- VYVANSE (Drug) $299.46
- MYDAYIS (Drug) $271.08
- VRAYLAR (Drug) $259.03
- LATUDA (Drug) $213.96
- Fanapt (Drug) $201.77
- SUBLOCADE (Drug) $153.05
- ABILIFY MAINTENA (Drug) $141.63
- SPRAVATO (Drug) $130.01
- NeuroStar TMS Therapy (Device) $122.46
- Trintellix (Drug) $100.66
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $87.05
- Adzenys XR-ODT (Drug) $71.84
- QUILLICHEW ER (Drug) $70.10
- INGREZZA (Drug) $62.08
- TRINTELLIX (Drug) $60.86
- METHYLPHENIDATE 72 (Drug) $60.17
- BELSOMRA (Drug) $58.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Springfield
Dr. Kalpana Vishnupad, M.d, M.D
Psychiatry — Payments: $63,945
Dr. Andrea Stonecipher, M.d, M.D
Psychiatry — Payments: $28,609
Dr. Shirlann Knight, M.d, M.D
Psychiatry — Payments: $9,255
Dr. Umamaheswara Vellanki, M.d, M.D
Psychiatry — Payments: $9,082
Dr. Dennis Dobard, M.d, M.D
Psychiatry — Payments: $8,804
Dr. Obiora Onwuameze, Md, Ms, Phd, MD, MS, PHD
Psychiatry — Payments: $6,358